2018 AANS Annual Scientific Meeting-Point/Counterpoint Session: Asymptomatic Carotid Disease

Point/Counterpoint Session: Asymptomatic Carotid Disease - Second Panelist

Video Transcription

Video Summary

In this video, the speaker discusses cerebrovascular disease tools and trials, specifically focusing on carotid angioplasty and stenting. The speaker mentions that carotid doppler is the best way to screen patients for carotid disease, as it provides information on stenosis and plaque characteristics. They also highlight the importance of assessing silent embolic infarctions using transcranial dopplers in asymptomatic patients. CT perfusion is recommended for patients with critical stenosis and asymptomatic disease. The speaker discusses the different management options, including medical therapy, endarterectomy, and angioplasty with distal or proximal embolic protection. They emphasize the need for physician experience and the importance of embolic protection during procedures. The speaker presents data from various trials, including the CREST trial, to support the use of both endarterectomy and angioplasty and stenting in the treatment of carotid disease. They also mention the development of next-generation stents that offer better plaque prolapse protection. The video concludes by discussing the ongoing CREST-2 trial and the need for a multidisciplinary approach in managing carotid disease. Overall, the speaker highlights the evolving strategies and options available for the treatment of cerebrovascular disease. No credits were mentioned in the video.

Asset Caption

Adnan H. Siddiqui, MD, PhD, FAANS

Keywords

carotid angioplasty

carotid stenting

carotid doppler

silent embolic infarctions

CT perfusion